{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:33:23Z","timestamp":1773660803440,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["18-15-00021"],"award-info":[{"award-number":["18-15-00021"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11033-022-07340-1","type":"journal-article","created":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T06:02:51Z","timestamp":1647669771000},"page":"4089-4093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation"],"prefix":"10.1007","volume":"49","author":[{"given":"Mark E.","family":"Mazin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei A.","family":"Yarushkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliya A.","family":"Pustylnyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Prokopyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-5534","authenticated-orcid":false,"given":"Vladimir O.","family":"Pustylnyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,19]]},"reference":[{"issue":"5","key":"7340_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.apsb.2016.06.011","volume":"6","author":"J Yan","year":"2016","unstructured":"Yan J, Xie W (2016) A brief history of the discovery of PXR and CAR as xenobiotic receptors. Acta Pharm Sin B 6(5):450\u2013452. https:\/\/doi.org\/10.1016\/j.apsb.2016.06.011","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"7340_CR2","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/hep.22475","volume":"48","author":"WE Blanco-Bose","year":"2008","unstructured":"Blanco-Bose WE, Murphy MJ, Ehninger A, Offner S, Dubey C, Huang W, Moore DD, Trumpp A (2008) C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. Hepatology 48(4):1302\u20131311. https:\/\/doi.org\/10.1002\/hep.22475","journal-title":"Hepatology"},{"issue":"6","key":"7340_CR3","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/me.2004-0520","volume":"19","author":"W Huang","year":"2005","unstructured":"Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G, Moore DD (2005) Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 19(6):1646\u20131653. https:\/\/doi.org\/10.1210\/me.2004-0520","journal-title":"Mol Endocrinol"},{"issue":"4","key":"7340_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/17425255.2020.1746268","volume":"16","author":"R Shizu","year":"2020","unstructured":"Shizu R, Yoshinari K (2020) Nuclear receptor CAR-mediated liver cancer and its species differences. Expert Opin Drug Metab Toxicol 16(4):343\u2013351. https:\/\/doi.org\/10.1080\/17425255.2020.1746268","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"7340_CR5","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1007\/s00204-020-02935-8","volume":"94","author":"A Braeuning","year":"2020","unstructured":"Braeuning A, Pavek P (2020) \u03b2-catenin signaling, the constitutive androstane receptor and their mutual interactions. Arch Toxicol 94(12):3983\u20133991. https:\/\/doi.org\/10.1007\/s00204-020-02935-8","journal-title":"Arch Toxicol"},{"key":"7340_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108065","volume":"672","author":"AA Yarushkin","year":"2019","unstructured":"Yarushkin AA, Mazin ME, Pustylnyak YA, Prokopyeva EA, Pustylnyak VO (2019) Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN. Arch Biochem Biophys 672:108065. https:\/\/doi.org\/10.1016\/j.abb.2019.108065","journal-title":"Arch Biochem Biophys"},{"key":"7340_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.semcdb.2019.10.007","volume":"100","author":"M Ozaki","year":"2020","unstructured":"Ozaki M (2020) Cellular and molecular mechanisms of liver regeneration: proliferation, growth, death and protection of hepatocytes. Semin Cell Dev Biol 100:62\u201373. https:\/\/doi.org\/10.1016\/j.semcdb.2019.10.007","journal-title":"Semin Cell Dev Biol"},{"key":"7340_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jhep.2012.01.029","volume":"57","author":"B Gao","year":"2012","unstructured":"Gao B, Wang H, Lafdil F, Feng D (2012) STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol 57:430\u2013441. https:\/\/doi.org\/10.1016\/j.jhep.2012.01.029","journal-title":"J Hepatol"},{"key":"7340_CR9","doi-asserted-by":"publisher","first-page":"28411","DOI":"10.1074\/jbc.M202807200","volume":"277","author":"W Li","year":"2002","unstructured":"Li W, Liang X, Kellendonk C, Poli V, Taub R (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411\u201328417. https:\/\/doi.org\/10.1074\/jbc.M202807200","journal-title":"J Biol Chem"},{"key":"7340_CR10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/labinvest.3700630","volume":"87","author":"A Moh","year":"2007","unstructured":"Moh A, Iwamoto Y, Chai GX, Zhang SS, Kano A, Yang DD, Zhang W, Wang J, Jacoby JJ, Gao B, Flavell RA, Fu XY (2007) Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest 87:1018\u20131028. https:\/\/doi.org\/10.1038\/labinvest.3700630","journal-title":"Lab Invest"},{"key":"7340_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/cancers6020897","volume":"6","author":"RL Carpenter","year":"2014","unstructured":"Carpenter RL, Lo HW (2014) STAT3 target genes relevant to human cancers. Cancers 6:897\u2013925. https:\/\/doi.org\/10.3390\/cancers6020897","journal-title":"Cancers"},{"key":"7340_CR12","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1038\/sj.onc.1203947","volume":"19","author":"D Sinibaldi","year":"2000","unstructured":"Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R (2000) Induction of p21WAF1\/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419\u20135427. https:\/\/doi.org\/10.1038\/sj.onc.1203947","journal-title":"Oncogene"},{"key":"7340_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.189.1.63","volume":"189","author":"N Kiuchi","year":"1999","unstructured":"Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M, Hirano T (1999) STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 189:63\u201373. https:\/\/doi.org\/10.1084\/jem.189.1.63","journal-title":"J Exp Med"},{"key":"7340_CR14","doi-asserted-by":"publisher","first-page":"173135","DOI":"10.1016\/j.ejphar.2020.173135","volume":"879","author":"AA Yarushkin","year":"2020","unstructured":"Yarushkin AA, Mazin ME, Pustylnyak YA, Prokopyeva EA, Pustylnyak VO (2020) Activation of the Akt pathway by a constitutive androstane receptor agonist results in \u03b2-catenin activation. Eur J Pharmacol 879:173135. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173135","journal-title":"Eur J Pharmacol"},{"key":"7340_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.taap.2013.05.008","volume":"271","author":"YA Kazantseva","year":"2013","unstructured":"Kazantseva YA, Yarushkin AA, Pustylnyak VO (2013) Dichlorodiphenyltrichloroethane technical mixture regulates cell cycle and apoptosis genes through the activation of CAR and ER\u03b1 in mouse livers. Toxicol Appl Pharmacol 271:137\u2013143. https:\/\/doi.org\/10.1016\/j.taap.2013.05.008","journal-title":"Toxicol Appl Pharmacol"},{"key":"7340_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114905","volume":"197","author":"J Skoda","year":"2021","unstructured":"Skoda J, Dohnalova K, Chalupsky K, Stahl A, Templin M, Maixnerova J, Micuda S, Gr\u00f8ntved L, Braeuning A, Pavek P (2021) Off-target lipid metabolism disruption by the mouse constitutive androstane receptor ligand TCPOBOP in humanized mice. Biochem Pharmacol 197:114905. https:\/\/doi.org\/10.1016\/j.bcp.2021.114905","journal-title":"Biochem Pharmacol"},{"key":"7340_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2005.03.027","volume":"43","author":"S Haga","year":"2005","unstructured":"Haga S, Ogawa W, Inoue H, Terui K, Ogino T, Igarashi R, Takeda K, Akira S, Enosawa S, Furukawa H, Todo S, Ozaki M (2005) Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J Hepatol 43:799\u2013807. https:\/\/doi.org\/10.1016\/j.jhep.2005.03.027","journal-title":"J Hepatol"},{"key":"7340_CR18","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1038\/sj.onc.1208894","volume":"24","author":"MK Ghosh","year":"2005","unstructured":"Ghosh MK, Sharma P, Harbor PC, Rahaman SO, Haque SJ (2005) PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells. Oncogene 24:7290\u20137300. https:\/\/doi.org\/10.1038\/sj.onc.1208894","journal-title":"Oncogene"},{"key":"7340_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bbrc.2018.06.032","volume":"504","author":"AA Yarushkin","year":"2018","unstructured":"Yarushkin AA, Mazin ME, Yunusova AY, Korchagina KV, Pustylnyak YA, Prokopyeva EA, Pustylnyak VO (2018) CAR-mediated repression of Cdkn1a(p21) is accompanied by the Akt activation. Biochem Biophys Res Commun 504:361\u2013366. https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.032","journal-title":"Biochem Biophys Res Commun"},{"key":"7340_CR20","doi-asserted-by":"publisher","first-page":"16840","DOI":"10.1074\/jbc.M100795200","volume":"276","author":"F Bienvenu","year":"2001","unstructured":"Bienvenu F, Gascan H, Coqueret O (2001) Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J Biol Chem 276:16840\u201316847. https:\/\/doi.org\/10.1074\/jbc.M100795200","journal-title":"J Biol Chem"},{"issue":"11","key":"7340_CR21","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1128\/MCB.17.11.6508","volume":"17","author":"J Chung","year":"1997","unstructured":"Chung J, Uchida E, Grammer TC, Blenis J (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17(11):6508\u20136516. https:\/\/doi.org\/10.1128\/MCB.17.11.6508","journal-title":"Mol Cell Biol"},{"issue":"24","key":"7340_CR22","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1038\/sj.onc.1202238","volume":"17","author":"N Jain","year":"1998","unstructured":"Jain N, Zhang T, Fong SL, Lim CP, Cao X (1998) Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 17(24):3157\u20133167. https:\/\/doi.org\/10.1038\/sj.onc.1202238","journal-title":"Oncogene"},{"key":"7340_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.taap.2015.07.004","volume":"288","author":"YA Kazantseva","year":"2015","unstructured":"Kazantseva YA, Yarushkin AA, Mostovich LA, Pustylnyak YA, Pustylnyak VO (2015) Xenosensor CAR mediates down-regulation of miR-122 and up-regulation of miR-122 targets in the liver. Toxicol Appl Pharmacol 288:26\u201332. https:\/\/doi.org\/10.1016\/j.taap.2015.07.004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"7340_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1039\/c8tx00008e","volume":"7","author":"BG Lake","year":"2018","unstructured":"Lake BG (2018) Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators. Toxicol Res 7(4):697\u2013717. https:\/\/doi.org\/10.1039\/c8tx00008e","journal-title":"Toxicol Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07340-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T20:27:43Z","timestamp":1654633663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07340-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,19]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["7340"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07340-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,19]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Federal Research Centre for Fundamental and Translational Medicine's Committee for Animal Care (Novosibirsk, Russia)reviewed and approved the experimental steps. Prior to\u00a0approval, the NIH criteria for the caring and usage of experimental animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}